Nucleotide and serotonin metabolism in platelets with defective secondary aggregation.
D000227:Adenine Nucleotides / Q000378:metabolism*; D000244:Adenosine Diphosphate / Q000032:analysis / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000032:analysis / Q000378:metabolism; D000293:Adolescent; D000417:Albinism / Q000209:etiology; D001791:Blood Platelet Disorders / Q000235:genetics / Q000378:metabolism*; D001792:Blood Platelets / Q000378:metabolism*; D002250:Carbon Radioisotopes; D002648:Child; D002845:Chromatography; D003094:Collagen / Q000494:pharmacology; D000242:Cyclic AMP / Q000096:biosynthesis; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D049454:Firefly Luciferin; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D008156:Luciferases; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism*; D013053:Spectrophotometry
D000227:Adenine Nucleotides; D002250:Carbon Radioisotopes; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D049454:Firefly Luciferin; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D003094:Collagen; D000242:Cyclic AMP; D008156:Luciferases; D004837:Epinephrine